Ischemia and Reperfusion Liver Injury is Reduced in the Absence of Toll-like Receptor 4
Author(s) -
Ziv BenAri,
O. Avlas,
Reut Fallach,
Hemda SchmilovitzWeiss,
Yelena Chepurko,
Orit Pappo,
Edith Hochhauser
Publication year - 2012
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000341432
Subject(s) - reperfusion injury , toll like receptor , receptor , ischemia , medicine , innate immune system
Toll-like receptor 4 (TLR4) is expressed on hepatic non-parenchymal cells and hepatocytes. Hepatic signaling through TLR4 is critical in the pathogenesis of ischemia reperfusion injury (IRI) and leads to the release of cytokines. The role of bone marrow-derived TLR4 in the early reperfusion stage is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom